Search for: "IN RE: INVOKANA (CANAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION" Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2017, 9:13 am by Tom Lamb
§ 1407, a motion was filed to establish IN RE: INVOKANA (CANAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION, MDL Docket No. 2750. [read post]
21 Feb 2018, 1:40 pm by Tom Lamb
IN RE: Invokana (Canagliflozin) Products Liability Litigation  MDL-2750 Number of lawsuits pending: 985Diabetes drugs in this MDL case: Invokana (canagliflozin) Invokamet (canagliflozin and metformin) Invokamet XR (canagliflozin and metformin extended-release) Primary side effects for these cases: Diabetic Ketoacidosis (DKA) Ketoacidosis Ketosis Leg Amputation Foot or Toe(s) Amputation Get more information… [read post]
2 Mar 2018, 11:26 am by Jeffrey Carr
Invokana is the brand name for canagliflozin, a diabetes drug that helps regulate blood sugar levels. [read post]
12 May 2017, 9:05 am by Tom Lamb
Other SLGT2 inhibitors include Invokana (canagliflozin) and Jardiance (empagliflozin).... [read post]
2 Nov 2017, 9:23 am by Clay Hodges
 As a product liability lawyer, I can’t diagnose your health issues and cannot connect any injury you may have suffered to testosterone or to any other drug. [read post]